0001104659-22-066269.txt : 20220531
0001104659-22-066269.hdr.sgml : 20220531
20220531083127
ACCESSION NUMBER: 0001104659-22-066269
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENTSUR RON
CENTRAL INDEX KEY: 0001251213
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 22980655
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
STREET 2: 20TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2217208-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-26
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001251213
BENTSUR RON
C/O NUVECTIS PHARMA, INC.,
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
1
1
0
Chairman & CEO
Common Stock
2022-05-26
4
P
0
500
15.90
A
2963114
D
Common Stock
2022-05-27
4
P
0
500
15.74
A
2963614
D
Includes 96,759 shares of restricted stock and 120,000 restricted stock units.
/s/ Ron Bentsur
2022-05-31